Patent details

EP2823312 Title: IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES

Basic Information

Publication number:
EP2823312
PCT Application Number:
EP2013054670
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP137103289
PCT Publication Number:
WO2013132040
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES
French Title of Invention:
IN VITRO ESSAI D'ACTIVITE DES VACCINS A BASE DE PROTEINES MÉNINGOCOCCIQUES
German Title of Invention:
IN VITRO-WIRKSAMKEITS BASIERTE ASSAY FÜR PROTEIN-BASIERTEN MENINGOKOKKEN-IMPFSTOFFE
SPC Number:

Dates

Filing date:
08/03/2013
Grant date:
07/08/2019
EP Publication Date:
14/01/2015
PCT Publication Date:
12/09/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2019
EP B1 Publication Date:
07/08/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/03/2020
Expiration date:
08/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/07/2019
 
 

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Inventor

1

Name:
GIULIANI, Marzia
Address:
Italy (IT)

2

Name:
MORI, Elena
Address:
Italy (IT)

Priority

Priority Number:
201261608293 P
Priority Date:
08/03/2012
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/03; G01N 33/569; G01N 33/577;

Publication

European Patent Bulletin

Issue number:
201932
Publication date:
07/08/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages